{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:47:21Z","timestamp":1793810841624,"version":"4.6.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.amjopharm.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T20:42:06Z","timestamp":1321044126000},"page":"364-377","source":"Crossref","is-referenced-by-count":217,"title":["Potentially Harmful Drug\u2013Drug Interactions in the Elderly: A Review"],"prefix":"10.1016","volume":"9","author":[{"given":"Lisa E.","family":"Hines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.10.004_bib1","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","article-title":"The science of drug therapy","author":"Oates","year":"2006"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00002018-200528090-00004","article-title":"The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions","volume":"28","author":"DuBuske","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2004.12.005","article-title":"Pharmacokinetics in older persons","volume":"2","author":"Cusack","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-3565(25)22660-X","article-title":"Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men","volume":"245","author":"Crowley","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3565(24)36457-2","article-title":"Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers","volume":"280","author":"Loi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0531-5565(93)90068-O","article-title":"Aging and the response to inhibition and induction of theophylline metabolism","volume":"28","author":"Vestal","year":"1993","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-5347(25)00297-6","article-title":"Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men","volume":"241","author":"Vestal","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","article-title":"Pharmacokinetics and drug metabolism in the elderly","volume":"41","author":"Klotz","year":"2009","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","article-title":"Pharmacodynamics in older adults: a review","volume":"5","author":"Bowie","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1345\/aph.1A484","article-title":"Drug\u2013drug interactions in the elderly","volume":"36","author":"Bjorkman","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1532-5415.2008.01648.x","article-title":"Quality of pharmacotherapy and outcomes for older veterans discharged from the emergency department","volume":"56","author":"Hastings","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug\u2013drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib14","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib15","series-title":"Therapeutics in the Elderly","author":"Delafuente","year":"2001"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2003.04.004","article-title":"Understanding and preventing drug interactions in elderly patients","volume":"48","author":"Delafuente","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1543-5946(05)00030-9","article-title":"Drug\u2013drug interactions in older adults: which ones matter?","volume":"3","author":"Hanlon","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib18","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","article-title":"Drug\u2013drug interactions among elderly patients hospitalized for drug toxicity","volume":"289","author":"Juurlink","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/archinternmed.2010.142","article-title":"Trimethoprim\u2013sulfamethoxazole\u2013induced hyperkalemia in patients receiving inhibitors of the renin\u2013angiotensin system: a population\u2013based study","volume":"170","author":"Antoniou","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/pds.2031","article-title":"Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults","volume":"19","author":"Zint","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1503\/cmaj.100702","article-title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers","volume":"183","author":"Wright","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2009.127","article-title":"Macrolide-induced digoxin toxicity: a population\u2013based study","volume":"86","author":"Gomes","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00228-009-0698-4","article-title":"Risk of digoxin intoxication caused by clarithromycin\u2013digoxin interactions in heart failure patients: a population\u2013based study","volume":"65","author":"Chan","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1532-5415.2004.52221.x","article-title":"Drug\u2013induced lithium toxicity in the elderly: a population\u2013based study","volume":"52","author":"Juurlink","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2125.2010.03866.x","article-title":"Trimethoprim\/sulfamethoxazole\u2013induced phenytoin toxicity in the elderly: a population\u2013based study","volume":"71","author":"Antoniou","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2010.74","article-title":"Anti\u2013infectives and the risk of severe hypoglycemia in users of glipizide or glyburide","volume":"88","author":"Schelleman","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib28","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00228-010-0985-0","article-title":"Ciprofloxacin\u2013induced theophylline toxicity: a population\u2013based study","volume":"67","author":"Antoniou","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.2008.150","article-title":"Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding","volume":"84","author":"Schelleman","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archinternmed.2010.37","article-title":"Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti\u2013infective agents: a population\u2013based study","volume":"170","author":"Fischer","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archinte.165.2.189","article-title":"Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX\u20132 inhibitors","volume":"165","author":"Battistella","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib33","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1345\/aph.1M284","article-title":"Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase\u20132 inhibitors in patients on warfarin","volume":"43","author":"Cheetham","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin\u2013angiotensin\u2013aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.ajkd.2010.11.006","article-title":"Hospital admissions for hyperkalemia with trimethoprim\u2013sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections","volume":"57","author":"Lam","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","article-title":"Benzodiazepines and risk of hip fractures in older people: a review of the evidence","volume":"17","author":"Cumming","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","article-title":"Psychotropic medications and the risk of fracture: a meta\u2013analysis","volume":"30","author":"Takkouche","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib38","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","article-title":"Zolpidem use and hip fractures in older people","volume":"49","author":"Wang","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00002018-200528120-00008","article-title":"Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population","volume":"28","author":"French","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2165\/00003088-199223020-00004","article-title":"Pharmacokinetic drug interactions of macrolides","volume":"23","author":"Periti","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.amjhyper.2005.11.003","article-title":"Interaction of grapefruit juice and calcium channel blockers","volume":"19","author":"Sica","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin","volume":"50","author":"Westphal","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-105-3-329","article-title":"Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients","volume":"105","author":"Abernethy","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)12784-5","article-title":"Aging alters verapamil elimination and dynamics: single dose and steady\u2013state responses","volume":"255","author":"Schwartz","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/00003088-200746120-00004","article-title":"Role of p\u2013glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies","volume":"46","author":"Eberl","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00023210-200923040-00005","article-title":"Lithium: updated human knowledge using an evidence\u2013based approach","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s002280050325","article-title":"Lithium intoxication in an elderly patient after combined treatment with losartan","volume":"52","author":"Blanche","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00004714-200006000-00022","article-title":"Potential drug interaction between lithium and valsartan","volume":"20","author":"Leung","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4088\/JCP.v62n0312e","article-title":"Lithium intoxication after administration of AT1 blockers","volume":"62","author":"Zwanzger","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.30.6.631","article-title":"Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively","volume":"30","author":"Wen","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/clpt.1982.37","article-title":"Age and phenytoin kinetics in adult epileptics","volume":"31","author":"Bauer","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2004.04.006","article-title":"Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data","volume":"59","author":"Battino","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/17425250902806424","article-title":"Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions","volume":"5","author":"Holstein","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib56","series-title":"Drug Interactions Analysis and Management","author":"Hansten","year":"2010"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2125.2006.02836.x","article-title":"Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide","volume":"63","author":"Lilja","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1592\/phco.28.1.82","article-title":"Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting","volume":"28","author":"LaPlante","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/600294","article-title":"Severe dysglycemia with the fluoroquinolones: a class effect?","volume":"49","author":"Aspinall","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-200831040-00002","article-title":"Dysglycaemias and fluoroquinolones","volume":"31","author":"Lewis","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib61","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","article-title":"Coprescription of tamoxifen and medications that inhibit CYP2D6","volume":"28","author":"Sideras","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib62","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1200\/JCO.2005.03.3266","article-title":"Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes","volume":"23","author":"Goetz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib63","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.2007.12.2705","article-title":"Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes","volume":"25","author":"Schroth","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib64","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2009.1420","article-title":"Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen","volume":"302","author":"Schroth","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-006-9428-0","article-title":"The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen","volume":"101","author":"Goetz","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib66","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/j.1552-4604.1989.tb03394.x","article-title":"Effect of quinolone antimicrobials on theophylline pharmacokinetics","volume":"29","author":"Prince","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-2952(95)00120-O","article-title":"Characterization of human cytochromes P450 involved in theophylline 8\u2013hydroxylation","volume":"50","author":"Zhang","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2125.1995.tb04453.x","article-title":"The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects","volume":"39","author":"Batty","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib69","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14656566.7.6.639","article-title":"Drug interactions during therapy with three major groups of antimicrobial agents","volume":"7","author":"Shakeri\u2013Nejad","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib70","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1378\/chest.101.3.883-b","article-title":"Role of ciprofloxacin in fatal seizures","volume":"101","author":"Bader","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(90)90519-J","article-title":"Theophylline toxicity: clinical features of 116 consecutive cases","volume":"88","author":"Sessler","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000441-200003000-00007","article-title":"Effect of disease states on theophylline serum concentrations: are we still vigilant?","volume":"319","author":"Self","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib73","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(96)00140-4","article-title":"Human P450 metabolism of warfarin","volume":"73","author":"Kaminsky","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib75","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1046\/j.1532-5415.2002.50380.x","article-title":"The use of oral anticoagulants (warfarin) in older people","volume":"50","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib76","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","article-title":"Concurrent use of nonsteroidal anti\u2013inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07853890903186168","article-title":"The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients","volume":"41","author":"Hauta-Aho","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib78","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00228-005-0947-0","article-title":"Main comedications associated with major bleeding during anticoagulant therapy with coumarins","volume":"61","author":"Penning-van Beest","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib79","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2146\/ajhp040567","article-title":"Assessment of potential drug\u2013drug interactions with a prescription claims database","volume":"62","author":"Malone","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib80","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib81","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000319744","article-title":"Antidepressants: clinically relevant drug interactions to be considered","volume":"86","author":"Schellander","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib83","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/11318880-000000000-00000","article-title":"Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly","volume":"26","author":"Vieweg","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib84","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/138920008784746373","article-title":"Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug\u2013drug interactions","volume":"9","author":"Urichuk","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib85","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjopharm.2010.10.004","article-title":"A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties","volume":"8","author":"Taipale","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib86","first-page":"225","article-title":"The cognitive impact of anticholinergics: a clinical review","volume":"4","author":"Campbell","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib87","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1331\/154434504773062591","article-title":"Identification of serious drug\u2013drug interactions: results of the partnership to prevent drug\u2013drug interactions","volume":"44","author":"Malone","year":"2004","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.amjopharm.2011.10.004_bib88","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1532-5415.2005.53112.x","article-title":"Suboptimal prescribing in elderly outpatients: potentially harmful drug\u2013drug and drug\u2013disease combinations","volume":"53","author":"Zhan","year":"2005","journal-title":"J Am Geriatr Soc"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:37:01Z","timestamp":1741912621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1543594611001760"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.10.004","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}